MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Alexion Pharmaceuticals Company Profile (NASDAQ:ALXN)

Consensus Ratings for Alexion Pharmaceuticals (NASDAQ:ALXN) (?)
Ratings Breakdown: 7 Hold Rating(s), 14 Buy Rating(s), 1 Strong Buy Rating(s)
Consensus Rating:Buy (Score: 2.73)
Consensus Price Target: $205.33 (45.20% upside)

Analysts' Ratings History for Alexion Pharmaceuticals (NASDAQ:ALXN)
Show:
DateFirmActionRatingPrice TargetActions
4/30/2016Morgan StanleyReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/30/2016BMO Capital MarketsDowngradeBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/30/2016Leerink SwannReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/28/2016Cowen and CompanyReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/28/2016Brean CapitalReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/28/2016Piper JaffrayReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/26/2016OppenheimerReiterated RatingOutperform$228.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/7/2016Robert W. BairdDowngradeOutperform -> Neutral$221.00 -> $170.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/25/2016Citigroup Inc.Initiated CoverageNeutral$165.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/22/2016Goldman SachsLower Price Target$186.00 -> $168.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/8/2016Jefferies GroupReiterated RatingHold$190.00 -> $165.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/5/2016Bank of AmericaReiterated RatingBuy$227.00 -> $204.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/4/2016Stifel NicolausLower Price TargetBuy$245.00 -> $230.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/4/2016JPMorgan Chase & Co.Lower Price Target$225.00 -> $185.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/4/2016BarclaysLower Price TargetEqual Weight$202.00 -> $175.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/19/2016Credit SuisseInitiated CoverageNeutral$201.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/7/2016BTIG ResearchDowngradeBuy -> NeutralView Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/6/2016SunTrustInitiated CoverageBuy$225.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/13/2015Raymond JamesReiterated RatingStrong-Buy$225.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/4/2015Deutsche BankReiterated RatingBuy$215.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/23/2015Sanford C. BernsteinSet Price TargetBuy$267.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/7/2015NomuraUpgradeNeutral -> Buy$222.00 -> $246.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 5/5/2014 forward)
            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha